1. Home
  2. TLSA vs EXFY Comparison

TLSA vs EXFY Comparison

Compare TLSA & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.25

Market Cap

155.3M

Sector

Health Care

ML Signal

HOLD

Logo Expensify Inc.

EXFY

Expensify Inc.

HOLD

Current Price

$1.82

Market Cap

156.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSA
EXFY
Founded
2013
2008
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
155.3M
156.2M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
TLSA
EXFY
Price
$1.25
$1.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.50
AVG Volume (30 Days)
184.2K
2.4M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$142,101,000.00
Revenue This Year
N/A
$0.42
Revenue Next Year
N/A
$0.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.06
52 Week Low
$1.04
$0.69
52 Week High
$2.60
$2.26

Technical Indicators

Market Signals
Indicator
TLSA
EXFY
Relative Strength Index (RSI) 52.91 61.20
Support Level $1.16 $1.37
Resistance Level $1.44 N/A
Average True Range (ATR) 0.11 0.16
MACD 0.02 0.00
Stochastic Oscillator 48.08 70.23

Price Performance

Historical Comparison
TLSA
EXFY

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app. Small and medium-sized businesses (SMBs) are the cornerstone of the global economy, making up almost all businesses and the majority of employment in Organization for Economic Co-operation and Development (OECD) member countries.

Share on Social Networks: